Assurance Infusion Recalls Quadmix Injection Vials Due to Sterility Concerns
Assurance Infusion is recalling 190 vials of Quadmix injection nationwide due to a lack of sterility assurance. The recall covers nine specific lots distributed across the United States.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. According to the rubric, FDA Class II recalls involving significant injury or property damage reports, or in this case, a critical sterility failure in an injectable drug, align with a Severe rating (Score 4) as it poses a significant risk of harm, though not explicitly Class I.
Plain-English summary
Assurance Infusion is recalling 190 vials of QUADMIX 30MG/2MG/20MCG/100MCG/ML INJ in 1 mL vials. The recall was initiated because of a lack of sterility assurance in the product. The affected product is distributed nationwide within the United States.
The recall covers nine specific lots with the following identifiers and expiration dates: 07012019@30 (Exp. 12/28/2019), 08052019@13 (Exp. 02/01/2020), 09252019@15 (Exp. 03/23/2020), 10292019@12 (Exp. 04/26/2020), 10092019@6 (Exp. 03/04/2020), 10162019@12 (Exp. 04/13/2020), 12042019@31 (Exp. 01/18/2020), 12162019@35 (Exp. 01/30/2020), and 11262019@37 (Exp. 05/24/2020).
Consumers and healthcare providers should check their inventory for these specific lot numbers. If the product is found, it should be removed from use and returned to Assurance Infusion at (713) 533-8800.
The recalled product
- Product
- QUADMIX 30MG/2MG/20MCG/100MCG/ML INJ in 1 mL vial Assurance Infusion (713) 533-8800
- Manufacturer
- Assurance Infusion
- Category
- Drug — Injectable Medication
- Affected units
- 190
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (9)
- Lots: 07012019@30 Exp. 12/28/2019
- 08052019@13 Exp. 02/01/2020
- 09252019@15 Exp. 03/23/2020
- 10292019@12 Exp. 04/26/2020
- 10092019@6 Exp. 03/04/2020
- 10162019@12 Exp. 04/13/2020
- 12042019@31 Exp. 01/18/2020
- 12162019@35 Exp. 01/30/2020
- 11262019@37 Exp. 05/24/2020
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 118 recalled by Assurance Infusion under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 118 products in this recall →Related recalls
Same manufacturer · Assurance Infusion
See all →- SevereAssurance Infusion Recalls Buprenorphine and Hydromorphone Injection Due to Sterility Concerns
FDA (Drugs) · 2020-01-22
- SevereAssurance Infusion Recalls Hydromorphone Injection Due to Sterility Concerns
FDA (Drugs) · 2020-01-22
- SevereAssurance Infusion Recalls Fentanyl Syringes Due to Sterility Concerns
FDA (Drugs) · 2020-01-22
- SevereAssurance Infusion Recalls Morphine Injection Due to Sterility Concerns
FDA (Drugs) · 2020-01-22
- SevereAssurance Infusion Recalls Buprenorphine and Morphine Injection Due to Sterility Concerns
FDA (Drugs) · 2020-01-22
Same hazard · sterility failure
See all →- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereTransvenous Pacing Electrode Tray with Bipolar Balloon Pacing Electrode Recalled
FDA (Devices) · 2026-07-22
- SevereArterial Line Kit with Lidocaine HCL Injection Fails Sterility Testing
FDA (Devices) · 2026-07-22
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22